Our previous studies demonstrated that ICA II could ameliorate endothelial dysfunction by regulating the MAPK pathway and Akt-eNOS signaling pathway in diabetic human cavernous endothelial cells (HCECs) (Li et al., 2015; Lei et al., 2018). This evidence concerns the gene AKT1 and endothelial dysfunction.